Benjamin T. Dake, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 8,480 shares at $20.16 ($171K) on 2022-10-17, disclosed to the SEC on 2022-10-18.
Open-market sale of $171k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.05 | 110 | $2K | 1.3% |
| 2 | $20.16 | 4,185 | $84K | 49.4% |
| 3 | $20.16 | 4,185 | $84K | 49.4% |
| Total | $20.16 avg | 8,480 | $171K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-28 | $619K | — | Filing → |
| AVTE | SELL | 2024-03-27 | $192K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $1.8M | — | Filing → |